InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Altman Michael Seth. Officer active across 5 companies, notably Nautilus Biotechnology, Inc.. Aggregated, 5 disclosures have been recorded. Activity tracked since 15 July 2021. The latest transaction was disclosed on 13 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Altman Michael Seth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
2,066,250 sharesCommon StockSEC:0001746738-26-000003:0
499,000 sharesClass A ordinary sharesSEC:0001140361-24-035164:0
286,250 shares@ US$10.00100.0% of flowClass A ordinary sharesSEC:0001140361-24-030023:0
499,000 shares@ US$10.00100.0% of flowClass A ordinary sharesSEC:0001140361-21-024476:0
3,647,500 sharesCommon StockSEC:0001140361-21-020674:0
5 of 5 declarations
About Altman Michael Seth
ALTMAN MICHAEL SETH is a declarant with 6 filings in total. The sampled recent filings run from 2021-06-11 to 2024-07-31, with a modal transaction nature shown as Attribution; the buy and sell amounts are both 0 in this recent sample. He is listed as Chief Financial Officer at ARYA Sciences Acquisition Corp V, Director at Nautilus Biotechnology, Inc., Chief Financial Officer at ARYA Sciences Acquisition Corp IV, and Chief Business Officer at Perceptive Capital Solutions Corp.
